Mounting evidence suggests that elevated uric acid isn’t just a marker—it may be a cause of high blood pressure. For years, endocrinologists and hypertension specialists have observed a consistent link between hyperuricemia (high serum uric acid) and elevated blood pressure. But today, this relationship is better understood and supported by solid science—from population-level studies to genetic analyses and clinical trials.
A Clear Pattern in Population Studies
Epidemiological studies have long hinted at this connection. People with higher uric acid levels tend to have higher rates of hypertension. This isn’t a one-off observation.
A comprehensive meta-analysis by Wang et al. looked at a wide range of observational studies and confirmed a dose-response relationship. The higher the uric acid, the higher the risk of developing hypertension [1]. That means this isn’t a random correlation—it follows a clear pattern.
Another major data source, NHANES, echoes the same story. A cross-sectional study of U.S. adults found a strong link between elevated serum uric acid and the presence of hypertension in the general population [2].
Genetic Studies Strengthen the Link
It’s one thing to observe a pattern. It’s another to prove that one factor causes another. That’s where genetic studies help.
Gill et al. used Mendelian randomization—a genetic tool that minimizes bias—to test this relationship. They found that individuals genetically predisposed to have higher uric acid also had higher blood pressure and cardiovascular risk [3]. These findings strengthen the argument that elevated uric acid may cause hypertension, not just coexist with it.
Why Does Uric Acid Raise Blood Pressure?
The biological pathways linking uric acid to high blood pressure are complex but increasingly clear. Elevated uric acid can:
- Impair the function of the endothelium (the inner lining of blood vessels)
- Increase oxidative stress and inflammation
- Activate the renin-angiotensin system (a hormonal system that raises blood pressure)
- Promote sodium retention in the kidneys
- Stimulate vascular smooth muscle growth, thickening arterial walls
Each of these effects can raise blood pressure on its own. Together, they create a potent environment for hypertension [4-5].
Do Uric Acid–Lowering Treatments Help?
Yes—especially in individuals with hyperuricemia. Several clinical trials have tested whether lowering uric acid improves blood pressure.
Meta-analyses suggest that medications like allopurinol and febuxostat can lead to modest reductions in blood pressure in patients with elevated uric acid [4]. These drugs are traditionally used to treat gout, but their cardiovascular effects are gaining attention. While the blood pressure-lowering effect isn’t dramatic, it’s consistent—adding another layer of evidence to the causal role of uric acid.
Why It Matters for Holistic Care
As hypertension specialists and endocrinologists, we look at high blood pressure through many lenses—hormonal, metabolic, renal, and cardiovascular. Uric acid affects all of them.
This is why holistic and personalized care is essential. A patient with mildly elevated blood pressure and high uric acid may not benefit from standard treatment alone. Addressing the uric acid—through diet, lifestyle, or medication—may be key.
Final Thoughts
The evidence is clear and growing stronger: elevated uric acid plays a direct role in raising blood pressure. This connection is supported by population studies, genetic research, and clinical trials. The mechanisms are diverse but interconnected. For many patients, especially those with metabolic syndrome or early-stage hypertension, addressing uric acid may offer a valuable, underused strategy in blood pressure control.

References
- Wang J, Qin T, Chen J, et al. PloS One. 2014;9(12):e114259. doi:10.1371/journal.pone.0114259. Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies.
- Wang Y, Ouyang Y, Zhang Y. Medicine. 2023;102(38):e34915. doi:10.1097/MD.0000000000034915. Relationship Between Serum Uric Acid and Hypertension in the General US Population Aged 20 Years and Older: A Cross-Sectional Study Based on NHANES 2007 to 2016.
- Gill D, Cameron AC, Burgess S, et al. Hypertension. 2021;77(2):383-392. doi:10.1161/HYPERTENSIONAHA.120.16547. Urate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials.
- Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Hypertension (Dallas, Tex. : 1979). 2022;79(9):1927-1936. doi:10.1161/HYPERTENSIONAHA.122.17956. Uric Acid and Hypertension: A Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.
- Ponticelli C, Podestà MA, Moroni G. Kidney International. 2020;98(5):1149-1159. doi:10.1016/j.kint.2020.05.056. Hyperuricemia as a Trigger of Immune Response in Hypertension and Chronic Kidney Disease.
About Dr. Gerti Tashko, MD
Dr. Gerti Tashko, MD, is a board-certified endocrinologist based in Montgomery County, Maryland. He is uniquely certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice offers comprehensive, root-cause-focused metabolic and endocrine care, available both virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to optimize long-term health outcomes.


